Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Public ClinicalTrials.gov record NCT01661634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of a continuous intravenous (IV) ularitide infusion on the clinical status and outcome of patients with acute decompensated heart failure (ADHF).
Study identification
- NCT ID
- NCT01661634
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Oct 31, 2015
- Completion
- Feb 29, 2016
- Last update posted
- Oct 22, 2018
2012 – 2016
United States locations
- U.S. sites
- 39
- U.S. states
- 23
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Montgomery | Alabama | 36106 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Littleton | Colorado | 80120 | — |
| Not listed | Trumbull | Connecticut | 06611 | — |
| Not listed | Washington D.C. | District of Columbia | 20422 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Lawrenceville | Georgia | 30046 | — |
| Not listed | Peoria | Illinois | 61606 | — |
| Not listed | Rockford | Illinois | 61107 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Alexandria | Louisiana | 71303 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Detroit | Michigan | 48235 | — |
| Not listed | Royal Oak | Michigan | 48073 | — |
| Not listed | Minneapolis | Minnesota | 55415 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Lincoln | Nebraska | 68526 | — |
| Not listed | Newark | New Jersey | 07107 | — |
| Not listed | Brooklyn | New York | 11203 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Middletown | Ohio | 45005 | — |
| Not listed | Toledo | Ohio | 43614 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Chattanooga | Tennessee | 37403 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Austin | Texas | 78758 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Midlothian | Virginia | 23114 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.
Recently updated Acute Decompensated Heart Failure trials
Other public records listing Acute Decompensated Heart Failure. Sorted by last update posted; newest first. Not a recommendation.
- NCT07572955: A Study Of Acute Decompensated Heart Failure Not yet recruiting
- NCT07018297: Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Not yet recruiting
- NCT06556810: IC14 for Treatment of Acute Decompensated Heart Failure Active, not recruiting
- NCT05206422: DORAYA-HF Early Feasibility Study Active, not recruiting
- NCT05291884: Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study Active, not recruiting
- NCT06898515: Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01661634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2018 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01661634 live on ClinicalTrials.gov.